首页> 外文期刊>Psychopharmacology >Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)
【24h】

Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)

机译:谷氨酸羧酸酯酶II(GCPII)抑制剂2-PMPA减少了大鼠合成的Cathinone MDPV的奖励作用:N-acetylaspartylylamate(NAAG)的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale Metabotropic glutamate 2 and 3 (mGluR2/3) receptors are implicated in drug addiction as they limit excessive glutamate release during relapse. N-acetylaspartylglutamate (NAAG) is an endogenous mGluR2/3 agonist that is inactivated by the glutamate carboxypeptidase II (GCPII) enzyme. GCPII inhibitors, and NAAG itself, attenuate cocaineseeking behaviors. However, their effects on the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) have not been examined.
机译:基本原理代谢谷氨酸2和3(MGLUR2 / 3)受体涉及吸毒成瘾,因为它们在复发过程中限制过量的谷氨酸释放。 N-acetylaspartylylyamate(NaAg)是内源性MgluR2 / 3激动剂,其由谷氨酸羧肽酶II(GCPII)酶灭活。 GCPII抑制剂和NAAG本身,减弱可卡因的行为。 然而,尚未检查它们对合成显式3,4-甲基二氧基吡罗烃酮(MDPV)的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号